A recent analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA) indicates that a potential 25% tariff on pharmaceutical imports into the United States could dramatically increase the cost of medications for American patients. The Ernst & Young report estimates that US drug costs could surge by nearly $51 billion annually. This could lead to a price increase…